Header

UZH-Logo

Maintenance Infos

IAPs must limit activation of RIP kinases by TNF Receptor 1 to prevent embryonic lethality


Moulin, M; Anderton, H; Voss, A K; Thomas, T; Wong, W W L; Bankovacki, A; Feltham, R; Chau, D; Cook, W D; Silke, J; Vaux, D L (2012). IAPs must limit activation of RIP kinases by TNF Receptor 1 to prevent embryonic lethality. EMBO Journal Online, 31(7):1679-1691.

Abstract

Inhibitor of apoptosis (IAP) proteins cIAP1, cIAP2, and XIAP (X-linked IAP) regulate apoptosis and cytokine receptor signalling, but their overlapping functions make it difficult to distinguish their individual roles. To do so, we deleted the genes for IAPs separately and in combina- tion. While lack of any one of the IAPs produced no overt phenotype in mice, deletion of cIap1 with cIap2 or Xiap resulted in mid-embryonic lethality. In contrast, Xiap-/- cIap2-/- mice were viable. The death of cIap2-/-cIap1-/- double mutants was rescued to birth by deletion of tumour necrosis factor (TNF) receptor 1, but not TNFR2 genes. Remarkably, hemizygosity for receptor-interacting protein kinase 1 (Ripk1) allowed Xiap-/-cIap1-/- double mutants to survive past birth, and prolonged cIap2-/-cIap1-/- embryonic survival. Similarly, deletion of Ripk3 was able to rescue the mid-gestation defect of cIap2-/-cIap1-/- embryos, as these embryos survived to E15.5. cIAPs are therefore required during development to limit activity of RIP kinases in the TNF receptor 1 signalling pathway.

Abstract

Inhibitor of apoptosis (IAP) proteins cIAP1, cIAP2, and XIAP (X-linked IAP) regulate apoptosis and cytokine receptor signalling, but their overlapping functions make it difficult to distinguish their individual roles. To do so, we deleted the genes for IAPs separately and in combina- tion. While lack of any one of the IAPs produced no overt phenotype in mice, deletion of cIap1 with cIap2 or Xiap resulted in mid-embryonic lethality. In contrast, Xiap-/- cIap2-/- mice were viable. The death of cIap2-/-cIap1-/- double mutants was rescued to birth by deletion of tumour necrosis factor (TNF) receptor 1, but not TNFR2 genes. Remarkably, hemizygosity for receptor-interacting protein kinase 1 (Ripk1) allowed Xiap-/-cIap1-/- double mutants to survive past birth, and prolonged cIap2-/-cIap1-/- embryonic survival. Similarly, deletion of Ripk3 was able to rescue the mid-gestation defect of cIap2-/-cIap1-/- embryos, as these embryos survived to E15.5. cIAPs are therefore required during development to limit activity of RIP kinases in the TNF receptor 1 signalling pathway.

Statistics

Citations

Dimensions.ai Metrics
98 citations in Web of Science®
104 citations in Scopus®
132 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

187 downloads since deposited on 17 Jan 2013
33 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Institute of Experimental Immunology
Dewey Decimal Classification:570 Life sciences; biology
610 Medicine & health
Uncontrolled Keywords:General Biochemistry, Genetics and Molecular Biology, General Immunology and Microbiology, General Neuroscience, Molecular Biology
Language:English
Date:2012
Deposited On:17 Jan 2013 13:59
Last Modified:18 Aug 2018 07:25
Publisher:Nature Publishing Group
ISSN:0261-4189
OA Status:Hybrid
Publisher DOI:https://doi.org/10.1038/emboj.2012.18

Download

Download PDF  'IAPs must limit activation of RIP kinases by TNF Receptor 1 to prevent embryonic lethality'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 1MB
View at publisher